Article
FDA Concerns Over Multiple Myeloma Immunotherapy Highlights AJPB Week in Review
Author(s):
Top articles of the week from The American Journal of Pharmacy Benefits.
5. Top 5 Vaccines Recommended for Patients with Diabetes
Patients with type 1 or type 2 diabetes may be at an increased risk of certain preventable conditions. Read more.
4. Veterans Affairs Expands Access to Lung Cancer Screening
The Department of Veterans Affairs and Bristol-Myers Squibb Foundation seek to increase lung cancer screening among veterans. Read more.3. Does the Opioid Epidemic Require an Emergency Declaration?
The opioid epidemic has resulted in 156% increase in overdose deaths from 2010 to 2015. Read more.
2. Plan Sponsors Highly Satisfied with Pharmacy Benefit Managers
Pharmacy Benefit Management Institute reports high satisfaction for services to plan sponsors. Read more.1. FDA Halts Multiple Immunotherapy Trials
Pharmacy Benefit Management Institute reports high satisfaction for services to plan sponsors. Read more.
FDA Approves Revumenib for the Treatment of Relapsed or Refractory Acute Leukemia
